Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Stock Ideas
ETF Research Tools
ETF Center
ETF Screener
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Portfolio
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
More...
Plans
News
Smart Portfolio
Expert Center
Ideas
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Stock Ideas
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETFs
ETF Research Tools
ETF Center
ETF Screener
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Dividends
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto
Crypto Center
Bitcoin
Ethereum
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Portfolio
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Newsletters
Newsletter Center
News
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
More
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing
ALIM
Stock Latest News
Market News
Alimera Soars as it Snaps Up Rights for Yutiq from EyePoint Pharma
11d ago
ALIM
EYPT
Press Releases
Alimera Sciences to Host Rescheduled Corporate Update Call on Thursday, May 18, 2023, at 8:30am ET
12d ago
ALIM
Press Releases
Alimera Sciences Reports First Quarter 2023 Results
15d ago
ALIM
Press Releases
Alimera Sciences to Report First Quarter 2023 Financial Results on May 15, 2023, and Provide Corporate Update
22d ago
ALIM
The Fly
Alimera Sciences price target lowered to $8 from $18 at Craig-Hallum
2M ago
ALIM
The Fly
Alimera Sciences announces expansion of agreement with Horus Pharma
2M ago
ALIM
Press Releases
Alimera Announces Expansion of Agreement with Distribution Partner Horus Pharma to Include Marketing ILUVIEN® in the Nordic Countries
2M ago
ALIM
Press Releases
Alimera Sciences Announces 2022 Financial Results and Business Update
2M ago
ALIM
The Fly
Alimera Sciences reports Q4 EPS (54c) vs (59c) last year
2M ago
ALIM
Pre-Earnings
Alimera Sciences (ALIM) Q4 Earnings Cheat Sheet
2M ago
ALIM
The Fly
Alimera Sciences announces transactions to bolster balance sheet
2M ago
ALIM
Press Releases
Alimera Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 31, 2023, and Provide Corporate Update
2M ago
ALIM
The Fly
Alimera Sciences appoints Roger Sawhney to board of directors
3M ago
ALIM
The Fly
Alimera Sciences announces submission of MAA in Switzerland for ILUVIEN
3M ago
ALIM
Press Releases
Alimera Announces Submission of Marketing Authorization Application in Switzerland for ILUVIEN®
3M ago
ALIM
The Fly
Alimera Sciences appoints Skibsted as Chief Financial Officer, SVP
5M ago
ALIM
RMTI
The Fly
Alimera Sciences agrees to amend existing loan, security agreement
6M ago
ALIM
SLRC
The Fly
Alimera Sciences announces recent meeting findings, data from PALADIN study
6M ago
ALIM
Press Releases
Alimera Sciences Announces Third Quarter 2022 Financial Results
7M ago
ALIM
Press Releases
Alimera Announces Agreement with Jaeb Center for Health Research on Behalf of the DRCR Retina Network
8M ago
ALIM
Press Releases
Alimera Announces Reimbursement of Uveitis Indication Granted for ILUVIEN® in Ireland
8M ago
ALIM
Press Releases
Alimera Announces Multiple Abstracts Highlighting ILUVIEN® Real World Data at EURETINA Annual Congress
9M ago
ALIM
Show More
You need to enable JavaScript to run this app.
